Highlighting This Investment Fund’s Top Stocks in the Healthcare Sector

Wall St. Watchdog reveals information regarding Marble Harbor Investment Counsel’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 16 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $36.045 million.

  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Marble Harbor Investment Counsel reported holding 224,827 shares with a market value of $11,830,396. This comprised 4.59% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 223,027 shares with a market value of $11,405,601. This comprised 5.13% of the total portfolio. The net change in shares for this position over the two quarters is -1,800. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Marble Harbor Investment Counsel reported holding 392,933 shares with a market value of $8,094,420. This comprised 3.14% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 394,583 shares with a market value of $6,976,228. This comprised 3.14% of the total portfolio. The net change in shares for this position over the two quarters is 1,650. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Marble Harbor Investment Counsel reported holding 57,183 shares with a market value of $3,803,813. This comprised 1.47% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 56,993 shares with a market value of $3,629,884. This comprised 1.63% of the total portfolio. The net change in shares for this position over the two quarters is -190. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Medtronic Inc. (NYSE:MDT): On 06/30/2011, Marble Harbor Investment Counsel reported holding 75,525 shares with a market value of $2,909,978. This comprised 1.13% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 75,225 shares with a market value of $2,500,479. This comprised 1.12% of the total portfolio. The net change in shares for this position over the two quarters is -300. About Company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, Marble Harbor Investment Counsel reported holding 36,610 shares with a market value of $2,136,193. This comprised 0.83% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 36,360 shares with a market value of $1,998,346. This comprised 0.9% of the total portfolio. The net change in shares for this position over the two quarters is -250. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Marble Harbor Investment Counsel reported holding 59,326 shares with a market value of $2,093,615. This comprised 0.81% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 59,226 shares with a market value of $1,936,690. This comprised 0.87% of the total portfolio. The net change in shares for this position over the two quarters is -100. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): On 06/30/2011, Marble Harbor Investment Counsel reported holding 50,951 shares with a market value of $2,456,857. This comprised 0.95% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 51,101 shares with a market value of $1,901,979. This comprised 0.86% of the total portfolio. The net change in shares for this position over the two quarters is 150. About Company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.
  • Stryker Corp. (NYSE:SYK): On 06/30/2011, Marble Harbor Investment Counsel reported holding 30,286 shares with a market value of $1,777,485. This comprised 0.69% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 30,186 shares with a market value of $1,422,666. This comprised 0.64% of the total portfolio. The net change in shares for this position over the two quarters is -100. About Company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment.
  • Edwards Lifesciences Corp. (NYSE:EW): On 06/30/2011, Marble Harbor Investment Counsel reported holding 18,326 shares with a market value of $1,597,661. This comprised 0.62% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 18,326 shares with a market value of $1,306,277. This comprised 0.59% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company’s products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.
  • Idexx Laboratories Inc. (NASDAQ:IDXX): On 06/30/2011, Marble Harbor Investment Counsel reported holding 16,005 shares with a market value of $1,241,348. This comprised 0.48% of the total portfolio. On 09/30/2011, Marble Harbor Investment Counsel reported holding 15,870 shares with a market value of $1,094,554. This comprised 0.49% of the total portfolio. The net change in shares for this position over the two quarters is -135. About Company: IDEXX Laboratories, Inc. provides diagnostic, detection, and information systems for veterinary, food, and water testing applications. The Company also operates an international network of veterinary reference laboratories. IDEXX offers its products to customers worldwide.

(Note: Data regarding Marble Harbor Investment Counsel’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet